MedTrace Logo

National Marrow Donor Program Long-Term Donor Follow-Up

NCT01362179 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 21974

Last updated 2020-10-20

No results posted yet for this study

Summary

This is an observational study of unstimulated bone marrow (BM) and filgrastim-mobilized peripheral blood stem cell (PBSC) donors. The primary goal is to evaluate the hypothesis that the incidence of targeted malignant, thrombotic and autoimmune disorders after unrelated hematopoietic stem cell donation are similar between unstimulated BM and filgrastim-mobilized PBSC donors.

Conditions

  • Hematologic Neoplasms

Sponsors & Collaborators

Principal Investigators

  • John P Miller, MD, PhD · National Marrow Donor Program

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-10-31
Primary Completion
2020-09-30
Completion
2020-10-15

Countries

  • United States
  • Puerto Rico

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01362179 on ClinicalTrials.gov